Tenax Therapeutics Statistics
Total Valuation
TENX has a market cap or net worth of $6.21 million. The enterprise value is -$5.93 million.
Market Cap | 6.21M |
Enterprise Value | -5.93M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
Earnings Date | Aug 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TENX has 1.96 million shares outstanding. The number of shares has increased by 948.64% in one year.
Shares Outstanding | 1.96M |
Shares Change (YoY) | +948.64% |
Shares Change (QoQ) | +390.70% |
Owned by Insiders (%) | 0.36% |
Owned by Institutions (%) | 7.26% |
Float | 1.84M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.50 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.12, with a Debt / Equity ratio of 0.03.
Current Ratio | 7.12 |
Quick Ratio | n/a |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -410.02 |
Financial Efficiency
Return on equity (ROE) is -89.70% and return on invested capital (ROIC) is -82.56%.
Return on Equity (ROE) | -89.70% |
Return on Assets (ROA) | -77.60% |
Return on Capital (ROIC) | -82.56% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.02M |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.01% in the last 52 weeks. The beta is 2.20, so TENX's price volatility has been higher than the market average.
Beta (5Y) | 2.20 |
52-Week Price Change | -87.01% |
50-Day Moving Average | 3.44 |
200-Day Moving Average | 12.35 |
Relative Strength Index (RSI) | 46.80 |
Average Volume (20 Days) | 22,876 |
Short Selling Information
The latest short interest is 9,892, so 0.51% of the outstanding shares have been sold short.
Short Interest | 9,892 |
Short Previous Month | 6,392 |
Short % of Shares Out | 0.51% |
Short % of Float | 0.54% |
Short Ratio (days to cover) | 0.51 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -10.60M |
Pretax Income | -10.10M |
Net Income | -10.10M |
EBITDA | -10.07M |
EBIT | -10.08M |
Earnings Per Share (EPS) | -$25.36 |
Balance Sheet
The company has $12.55 million in cash and $413,174 in debt, giving a net cash position of $12.14 million or $6.20 per share.
Cash & Cash Equivalents | 12.55M |
Total Debt | 413,174 |
Net Cash | 12.14M |
Net Cash Per Share | $6.20 |
Equity (Book Value) | 12.43M |
Book Value Per Share | 6.35 |
Working Capital | 12.43M |
Cash Flow
In the last 12 months, operating cash flow was -$9.34 million and capital expenditures $1,602, giving a free cash flow of -$9.34 million.
Operating Cash Flow | -9.34M |
Capital Expenditures | 1,602 |
Free Cash Flow | -9.34M |
FCF Per Share | -$7.66 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TENX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -948.64% |
Shareholder Yield | -948.64% |
Earnings Yield | -162.75% |
FCF Yield | -150.50% |
Analyst Forecast
The average price target for TENX is $30.00, which is 846.37% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $30.00 |
Price Target Difference | 846.37% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 3, 2024. It was a reverse split with a ratio of 1:80.
Last Split Date | Jan 3, 2024 |
Split Type | Reverse |
Split Ratio | 1:80 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |